Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation

Objectives. Transcriptomics of atrial fibrillation (AFib) in the setting of chronic primary mitral regurgitation (MR) remains to be characterized. We aimed to compare the gene expression profiles of patients with degenerative MR in AFib and sinus rhythm (SR) for a clearer picture of AFib pathophysio...

Full description

Saved in:
Bibliographic Details
Main Authors: Günseli Çubukçuoğlu Deniz, Serkan Durdu, Yeşim Doğan, Esra Erdemli, Hilal Özdağ, Ahmet Ruchan Akar
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Cardiovascular Therapeutics
Online Access:http://dx.doi.org/10.1155/2021/5516185
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549172743503872
author Günseli Çubukçuoğlu Deniz
Serkan Durdu
Yeşim Doğan
Esra Erdemli
Hilal Özdağ
Ahmet Ruchan Akar
author_facet Günseli Çubukçuoğlu Deniz
Serkan Durdu
Yeşim Doğan
Esra Erdemli
Hilal Özdağ
Ahmet Ruchan Akar
author_sort Günseli Çubukçuoğlu Deniz
collection DOAJ
description Objectives. Transcriptomics of atrial fibrillation (AFib) in the setting of chronic primary mitral regurgitation (MR) remains to be characterized. We aimed to compare the gene expression profiles of patients with degenerative MR in AFib and sinus rhythm (SR) for a clearer picture of AFib pathophysiology. Methods. After transcriptomic analysis and bioinformatics (n=59), differentially expressed genes were defined using 1.5-fold change as the threshold. Additionally, independent datasets from GEO were included as meta-analyses. Results. QRT-PCR analysis confirmed that AFib persistence was associated with increased expression molecular changes underlying a transition to heart failure (NPPB, P=0.002; ANGPTL2, P=0.002; IGFBP2, P=0.010), structural remodeling including changes in the extracellular matrix and cellular stress response (COLQ, P=0.003; COMP, P=0.028; DHRS9, P=0.038; CHGB, P=0.038), and cellular stress response (DNAJA4, P=0.038). Furthermore, AFib persistence was associated with decreased expression of the targets of structural remodeling (BMP7, P=0.021) and electrical remodeling (CACNB2, P=0.035; MCOLN3, P=0.035) in both left and right atrial samples. The transmission electron microscopic analysis confirmed ultrastructural atrial remodeling and autophagy in human AFib atrial samples. Conclusions. Atrial cardiomyocyte remodeling in persistent AFib is closely linked to alterations in gene expression profiles compared to SR in patients with primary MR. Study findings may lead to novel therapeutic targets. This trial is registered with ClinicalTrials.gov identifier: NCT00970034.
format Article
id doaj-art-7f12822328b34f3aa7371b1bdc84f9f5
institution Kabale University
issn 1755-5914
1755-5922
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Cardiovascular Therapeutics
spelling doaj-art-7f12822328b34f3aa7371b1bdc84f9f52025-02-03T06:12:04ZengWileyCardiovascular Therapeutics1755-59141755-59222021-01-01202110.1155/2021/55161855516185Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral RegurgitationGünseli Çubukçuoğlu Deniz0Serkan Durdu1Yeşim Doğan2Esra Erdemli3Hilal Özdağ4Ahmet Ruchan Akar5Stem Cell Institute, Ankara University, Ankara, TurkeyBiotechnology Institute, Ankara University, Ankara, TurkeyBiotechnology Institute, Ankara University, Ankara, TurkeyDepartment of Histology and Embryology, Ankara University School of Medicine, Ankara, TurkeyBiotechnology Institute, Ankara University, Ankara, TurkeyStem Cell Institute, Ankara University, Ankara, TurkeyObjectives. Transcriptomics of atrial fibrillation (AFib) in the setting of chronic primary mitral regurgitation (MR) remains to be characterized. We aimed to compare the gene expression profiles of patients with degenerative MR in AFib and sinus rhythm (SR) for a clearer picture of AFib pathophysiology. Methods. After transcriptomic analysis and bioinformatics (n=59), differentially expressed genes were defined using 1.5-fold change as the threshold. Additionally, independent datasets from GEO were included as meta-analyses. Results. QRT-PCR analysis confirmed that AFib persistence was associated with increased expression molecular changes underlying a transition to heart failure (NPPB, P=0.002; ANGPTL2, P=0.002; IGFBP2, P=0.010), structural remodeling including changes in the extracellular matrix and cellular stress response (COLQ, P=0.003; COMP, P=0.028; DHRS9, P=0.038; CHGB, P=0.038), and cellular stress response (DNAJA4, P=0.038). Furthermore, AFib persistence was associated with decreased expression of the targets of structural remodeling (BMP7, P=0.021) and electrical remodeling (CACNB2, P=0.035; MCOLN3, P=0.035) in both left and right atrial samples. The transmission electron microscopic analysis confirmed ultrastructural atrial remodeling and autophagy in human AFib atrial samples. Conclusions. Atrial cardiomyocyte remodeling in persistent AFib is closely linked to alterations in gene expression profiles compared to SR in patients with primary MR. Study findings may lead to novel therapeutic targets. This trial is registered with ClinicalTrials.gov identifier: NCT00970034.http://dx.doi.org/10.1155/2021/5516185
spellingShingle Günseli Çubukçuoğlu Deniz
Serkan Durdu
Yeşim Doğan
Esra Erdemli
Hilal Özdağ
Ahmet Ruchan Akar
Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation
Cardiovascular Therapeutics
title Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation
title_full Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation
title_fullStr Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation
title_full_unstemmed Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation
title_short Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation
title_sort molecular signatures of human chronic atrial fibrillation in primary mitral regurgitation
url http://dx.doi.org/10.1155/2021/5516185
work_keys_str_mv AT gunselicubukcuogludeniz molecularsignaturesofhumanchronicatrialfibrillationinprimarymitralregurgitation
AT serkandurdu molecularsignaturesofhumanchronicatrialfibrillationinprimarymitralregurgitation
AT yesimdogan molecularsignaturesofhumanchronicatrialfibrillationinprimarymitralregurgitation
AT esraerdemli molecularsignaturesofhumanchronicatrialfibrillationinprimarymitralregurgitation
AT hilalozdag molecularsignaturesofhumanchronicatrialfibrillationinprimarymitralregurgitation
AT ahmetruchanakar molecularsignaturesofhumanchronicatrialfibrillationinprimarymitralregurgitation